Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kagabu, S.
Right arrow Articles by Tanaka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kagabu, S.
Right arrow Articles by Tanaka, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 5, No. 5, 396-401, May 1999
© 1999 European Society of Human Reproduction and Embryology

Inhibitory effects of nitric oxide on the expression and activity of aromatase in human granulosa cells

Satoko Kagabu1, Hideya Kodama2,3, Jun Fukuda1, Akihiro Karube1, Masanori Murata1 and Toshinobu Tanaka1

1 Department of Obstetrics and Gynecology, Akita University School of Medicine, and 2 Akita University College of Allied Medical Science, 1–1–1 Hondo, Akita 010–8543, Japan


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
The aim of the present study was to explore the mechanisms by which nitric oxide (NO) may inhibit aromatase activity of human granulosa cells. Ovarian granulosa–luteal cells, obtained from patients undergoing in-vitro fertilization (IVF) were cultured in the presence of NO-related substances. After 24 h of culture, aromatase activity of the cells was significantly inhibited by treatment with the NO donors, SNAP or NOC12 at >=ISOdia>=10–4 M in a dose-dependent manner. Treatment with NO catabolites or a peroxynitrite-releasing compound, SIN1, had no significant influence. Treatment with SNAP at 10–3 M decreased relative aromatase mRNA values by 72% (P < 0.05) and intracellular cyclic AMP concentrations by 53% (P < 0.01). However, treatment with H89, an inhibitor of protein kinase A, did not inhibit aromatase activity. Since there were no significant effects of NO catabolites or peroxinitrite, the inhibitory action of NO donors on aromatase must be related to NO release. The action of NO is, in part, attributable to the down-regulation of aromatase gene transcription. Although NO decreased intracellular cAMP values, down-regulation of aromatase gene transcription may not be mediated by protein kinase A-dependent mechanisms.

aromatase/granulosa cells/mRNA/nitric oxide/ovary


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Nitric oxide (NO), which is formed from L-arginine by a constitutive calcium-dependent or by a pro-inflammatory cytokine-inducible NO synthase in vivo, has been recognized as an important regulator in a number of physiological and pathological processes (Moncada et al., 1991Go). In the ovary, both constitutive and inducible NO synthases are expressed (Van Voorhis, et al., 1995Go; Zackrisson et al., 1996Go), and hormonally or cytokine-regulated (Ben-Shlomo et al., 1994Go; Jablonka-Shariff and Olsen, 1997; Matsumi et al., 1998Go). Recently, NO has been implicated in a variety of ovarian activities, including ovulation (Shukovsky and Tsafriri, 1994Go; Bonello et al., 1996Go; Yamauchi et al., 1997Go), follicular atresia (Chun et al., 1995Go), luteolysis (Olson et al., 1996Go; Motta et al., 1997Go), and steroidogenesis (Van Voorhis et al., 1994Go).

In general, NO is thought to interact with the iron-containing enzymes, such as soluble guanylate cyclase (Ignarro et al., 1986Go), cyclo-oxygenase (Salvemini et al., 1993Go), and a number of the cytochrome P-450 enzymes (Wink et al., 1993Go; Stadler et al., 1994Go). Recently, several authors have reported an inhibitory action of NO on aromatase cytochrome P-450 (aromatase), the enzyme responsible for oestrogen biosynthesis. Addition of NO donors inhibited oestradiol secretion and aromatase activity, whereas inhibiting endogenous NO synthase enhanced oestradiol secretion from cultured ovarian granulosa cells of human (Van Voorhis et al., 1994Go), rat (Olson et al., 1996Go; Ahsan et al., 1997Go), and porcine (Masuda et al., 1997Go). In addition, in the in-vitro perfused rabbit ovaries, inhibition of endogenous NO synthase resulted in a significant elevation in the production of oestradiol stimulated by human chorionic gonadotrophin (HCG), and the concomitant administration of NO donors reversed this action (Yamauchi et al., 1997Go). These studies have suggested that NO may act as an important down-regulator of ovarian oestrogen synthesis during luteolysis (Olson et al., 1996Go) or ovulatory phase (Yamauchi et al., 1997Go).

Based on these reports, the aim of this study was to explore some of the mechanisms by which NO inhibits aromatase activity in human granulosa–luteal cells. Specifically, we sought to determine whether by-products of NO metabolism, including peroxinitrite, inhibited aromatase activity, and whether inhibitory actions of NO on aromatase involved down-regulation of aromatase gene transcription. In addition, we investigated whether NO modulates the intracellular cyclic AMP (cAMP) values of human granulosa–luteal cells.


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Media, probes and chemicals
Medium used for granulosa–luteal cell culture, was purchased from Wako Chemicals (GIT medium; Osaka, Japan). A human aromatase cDNA corresponding to nucleotides 105–1934, isolated from human placenta (Harada, 1988Go), was kindly provided by Dr Nobuhiro Harada through Tukuba Life Science Center at the Institute of Physical and Chemical Research (Tsukuba, Japan). A glyceraldehyde-3-phosphate dehydrogenase (G3PDH) cDNA probe was purchased from Toyobo (Osaka, Japan). Two types of NO donors, S-nitroso-L-acetyl penicillamine (SNAP), and ethanamine 1,1-diethyl-2-hydroxy-2-nitrosohydrazine (NOC12), and a peroxinitrite-releasing compound, 3-morpholinosyndnonimine (SIN1), were purchased from Dojindo Laboratories (Kumamoto, Japan). An inhibitor of protein kinase A, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulphonamide (H89), was purchased from Seikagaku Co. (Tokyo, Japan). The chemicals used were mainly purchased from Sigma Chemical Co (St Louis, MO, USA).

Ovarian follicular cell isolation and cell culture methods
Ovarian granulosa–luteal cells were obtained from women who underwent follicle aspiration for in-vitro fertilization (IVF), after informed consent was obtained according to the guidelines of our Institutional Review Board. All ovarian stimulations for IVF were performed with a standard mid-luteal administration of a gonadotrophin-releasing hormone agonist (GnRHa) (buserelin acetate; Hoechst Japan, Tokyo, Japan) and follicle stimulating hormone (FSH, Fertinorm; Serono Japan, Tokyo, Japan) stimulation protocol. When the leading follicle reached a size of 17 mm in diameter, the administration of GnRHa and FSH was stopped, and 10 000 IU of human chorionic gonadotropin (HCG) was administered. After 34 h following HCG injection, oocytes were recovered by transvaginal echo-guided follicle aspiration.

Follicular fluid obtained from several IVF patients was collected together and used for each experiment. In order to isolate granulosa–luteal cells, follicular fluid obtained was subjected to centrifugation at 3000 g for 20 min, and the cell pellets were suspended in phosphate-buffered saline (PBS; Sigma) containing 0.1% hyaluronidase. After incubation at 37°C for 20 min, the cells were placed on a 50% (v/v) Percoll cushion (Pharmacia LKB Biotechnology, Piscataway, NJ, USA), and subjected to centrifugation at 3000 g for 30 min. The cell pellets were washed twice with PBS and resuspended in GIT medium containing 50 IU/ml penicillin G and 50 µg/ml streptomycin. Approximately 2x104 cells in 500 µl of GIT medium were placed in each well of a collagen-coated 24-well multi-well plate (Celltight C1 Plate 24F; Sumitomo Bakelite Co, Tokyo, Japan). The cells were incubated at 37°C in an atmosphere of 5% CO2 in air. After 24 h of culture, adherent cells were washed with GIT medium, and used for experiments.

Measurement of aromatase activity and oestradiol
Aromatase activity of cultured granulosa–luteal cells was measured by a tritiated water production assay (Garzo and Dorrington, 1984Go), with slight modifications, e.g. a change of isotope from testosterone to androstenedione and increased incubation time. Briefly, the medium for granulosa–luteal cell culture was replaced with 500 µl of GIT medium containing 2 µCi of 1ß-3H(N) androstenedione (New England Nuclear, Boston, MA, USA), and cultured at 37°C for 4 h. After incubation, the GIT medium was transferred into the tubes, and the cells were washed with 200 µl of PBS. The PBS used for washing was combined with the previous GIT medium, and 250 mg/ml of Norit A-activated charcoal (Wako, Osaka, Japan) was added to each tube. After incubated at 4°C for 2 h, the charcoal was removed by centrifugation at 3000 g for 20 min, and the tritiated water (3H2O) in the supernatant was determined by counting 0.5 ml of aliquots in 10 ml of Aquasol (Amersham International plc, Amersham, UK) in a liquid scintillation counter (LSC950, Aloka, Tokyo, Japan). The radioactivity quantified in each tube was corrected by subtracting the radioactivity of the blank tube, which contained medium with isotope after incubation without cells.

Northern Blot analysis
Aromatase mRNA expression in human granulosa–luteal cells was measured by Northern Blotting analysis. At first, total RNA was isolated by a single-step guanidinium thiocyanate–phenol–chloroform extraction process (Chomczynski and Sacchi, 1987Go). Approximately 105 cells were suspended in 1 ml of ISOGENTM solution (Nippongene, Tokyo, Japan) in each experimental condition, and total RNA precipitated was dissolved in TE buffer (10 mM Tris–HCl and 1 mM EDTA, pH 7.5).

For Northern Blot analysis, 12 µl of total RNA from each sample was denatured at 65°C in the solution containing 25 µl formamide, 2.5 µl 20x MOPS buffer (0.4 M of 3-(N-morpholino) propanesulfonic acid, 100 mM of sodium acetate, 20 mM of EDTA, pH 7.0), and 8 µl formaldehyde, and fractionated by electrophoresis on 1% agarose gels containing MOPS buffer. The size separated RNA was transferred onto the nylon membranes (Hybond-N+; Amersham International) by the capillary blotting in 0.05 M of sodium hydroxide.

The probes were labelled with [32P]-deoxy-cytosine triphosphate (dCTP) using a random primed DNA labelling kit (Amersham International plc), and purified by passage through a ProbeQuantTM G-50 Micro Column (Pharmacia LKB, Uppsala, Sweden). The membranes were prehybridized in a rapid hybridization buffer (Rapid-hyb buffer RPN 1635; Amersham International plc) for 30 min at 65°C, and hybridization was performed at 65°C for 3 h in the buffer containing the labelled probe (2 ng/ml). After hybridization, the membrane was washed at 37°C for 15 min in a solution of 2 x sodium chloride/sodium citrate (SSC) and 0.1% sodium dodecyl sulphate (SDS), and then washed twice at 65°C for 15 min in a 1 x SSC and 0.1% SDS solution. The membrane was exposed to Kodak X-AR film at –80°C. After the determination of expression of aromatase mRNA, the probes were stripped and the membrane was subjected to autoradiography to show that no radioactivity remained. This membrane was then reprobed with a glyceraldehyde-3-phosphate dehydrogenase (G3PDH) cDNA. The relative amounts of aromatase mRNA expression in each sample were determined as a ratio of the intensity of aromatase mRNA expression to G3PDH mRNA expression on the autoradiogram determined by densitometric analysis using an image scanner, GT-6000 (Epson, Tokyo, Japan) and NIH Image software (National Institute of Health, Bethesda, MD, USA).

Measurement of cAMP
After incubation with or without SNAP for 24 h, granulosa–luteal cells were collected, and ~105 cells were suspended in 250 µl of ice-cold 6% (w/v) trichloroacetic acid (TCA). After sonication for 20 s, cAMP in the cells was extracted three times with water-saturated ethyl ether (2:1 v/v; Wako Chemicals). After removal of ether fraction, the specimens were stored frozen at –30°C until assay. Measurement of cAMP was performed by radioimmunoassay using a commercially available kit (Yamasa, Tokyo, Japan), according to the manufacturer's protocol.

Statistical analysis
Data were expressed as mean ± SEM, and compared by one-way analysis of variance followed by Scheffe's F test for multiple comparison. P < 0.05 was considered to be statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Effects of NO donors and NO-related substances on aromatase activity of cultured human granulosa cells
To investigate effects of NO, aromatase activity in granulosa–luteal cells was measured after incubation with various concentrations of SNAP for 24 h (Figure 1Go). Treatment with SNAP at concentrations of 10–4M or 10–3 M caused significant reduction in aromatase activity by 20% (P < 0.05) or 48% (P < 0.01) respectively. To ascertain whether or not the inhibitory effect of the NO donor on aromatase was related to NO released, another type of NO donor (NOC12), NO catabolites (sodium nitrite and sodium nitrate) and a peroxinitrite-releasing compound (SIN1) were added to the culture, and aromatase activity was measured after 24 h (Figure 2Go). There was no significant influence on aromatase activity by treatment with sodium nitrite, sodium nitrate and SIN1. On the other hand, NOC12 had quantitatively similar inhibitory effects on aromatase activity as SNAP.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Effects of nitric oxide (NO) on aromatase activity of human granulosa–luteal cells. The granulosa–luteal cells were incubated with indicated concentrations of S-nitroso-L-acetyl penicillamine (SNAP) for 24 h and the aromatase activity of the cells was measured by the tritiated water method. Values are shown as mean ± SEM of four experiments, each run in triplicate. Aromatase activity in the treated groups was expressed relative to that (100%) of the control group. The amount of tritium produced in the control wells was 5750 ± 460 d.p.m./105 cells. *P < 0.05 versus control, **P < 0.01 versus control.

 


View larger version (23K):
[in this window]
[in a new window]
 
Figure 2. Effects of nitric oxide (NO), NO catabolites, peroxinitrite, on aromatase activity of human granulosa–luteal cells. The granulosa–luteal cells were incubated with indicated concentrations of (a) sodium nitrite, sodium nitrate and (b), 3-morpholinosyndnonimine (SIN1) and ethanamine 1,1-diethyl-2-hydroxy-2-nitrosohydrazine (NOC12) for 24 h. The aromatase activity of the cells was measured by the tritiated water method. Values are shown as mean ± SEM of four experiments, each run in triplicate. Aromatase activity in the treated groups was expressed relative to that (100%) of the control group. The amount of tritium produced in the control wells was 7537 ± 603/105 cells. *P < 0.05 versus control, **P < 0.01 versus control.

 
Effects of NO donors on aromatase gene expression of cultured human granulosa cells
To test the effect of NO on aromatase gene transcription, aromatase mRNA expression in granulosa–luteal cells was quantified by Northern Blot analysis after 24 h of culture with SNAP at 10–3 or 10–4 M. As shown in Figure 3Go, transcripts of aromatase gene appeared as double bands located at 3.4 and 2.9 kb sites; this finding was consistent with previous reports (Means et al., 1989Go). Two major species of human aromatase transcripts are thought to be derived from the use of two different polyadenylation signals (Means et al., 1989Go). After 24 h of incubation with 10–3 M of SNAP, the relative amount of aromatase mRNA expression in granulosa–luteal cells was reduced by 72% (P < 0.05), compared with that of the control.




View larger version (72K):
[in this window]
[in a new window]
 
Figure 3. Effect of nitric oxide (NO) on aromatase mRNA expression in human granulosa–luteal cells. Ovarian granulosa–luteal cells were incubated with 10–4 or 10–3 M of S-nitroso-L-acetyl penicillamine (SNAP) for 24 h, and aromatase mRNA expression in the cells was quantified by Northern Blot analysis. (a) Representative result of the Northern Blot analysis. (b) Comparison of aromatase mRNA expression. The experiment was repeated two times (n = 3). Expression of aromatase mRNA in each group was determined by densitometric analysis, and presented as aromatase/glyceraldehyde-3-phosphate dehydrogenase (G3PDH) ratios, in which the control value was arbitrarily set to 1.0. *P < 0.05 versus control. Values are presented as mean ± SEM.

 
Effects of NO donors on intracellular cAMP values, and effects of A kinase inhibition or C kinase activation on aromatase activity in the cultured human granulosa cells
To investigate whether NO modulates intracellular cAMP values, these values were measured by radioimmunoassay after 24 h of incubation with various concentrations of SNAP (Figure 4Go) in granulosa–luteal cells. Treatment with 10–3 M of SNAP caused significant reduction of cAMP values by 53% (P < 0.01).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 4. Effects of nitric oxide (NO) on intracellular cyclic AMP (cAMP) concentrations of the human granulosa–luteal cells. Ovarian granulosa–luteal cells were incubated with the indicated concentrations of SNAP, and intracellular cAMP values were determined after 24 h of incubation. Values are shown as mean ± SEM of three experiments, each carried out in duplicate. *P < 0.01 versus control.

 
To test whether inhibition of A kinase or activation of C kinase decreases basal aromatase activity, such activity in granulosa–luteal cells was determined after 24 h of incubation with various concentrations of H89 or tetradecanoyl phorbol acetate (TPA). There was no significant effect on aromatase activity, when up to 20 µM of H89 was added to culture (Figure 5aGo). In contrast, addition of TPA >=1 nM decreased aromatase activity in a dose-dependent manner (Figure 5bGo).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 5. Effects of N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulphonamide (H89), a protein kinase A inhibitor, or tetradecanoyl phorbol acetate (TPA), a protein kinase C activator, on aromatase activity of the cultured human granulosa–luteal cells. Ovarian granulosa–luteal cells were incubated with the indicated concentrations of H89 for 24 h (a) or TPA for 24 h (b). Values are mean ± SEM of three experiments, each carried out in duplicate. Aromatase activity in the treated groups are expressed relative to that (100%) of the control group. The mean ± SEM for tritium produced in the control wells was 8921 ± 802 d.p.m./105 cells for H89 assay and 12450 ± 1120 d.p.m./105 cells for TPA assay. *P < 0.05 versus control, **P < 0.01 versus control.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Basal aromatase activity in cultured human granulosa–luteal cells was inhibited by treatment with two structurally dissimilar NO donors, and these results were in agreement with previous reports (Van Voorhis et al., 1994Go). In this study, we further explored the effect of molecules, generated as a result of NO metabolism, including major NO catabolites (nitrite and nitrate) and peroxinitrite (ONOO). Peroxinitrite, which is formed in the presence of superoxide and NO, has been reported to mediate various forms of tissue injury (Lipton et al., 1993Go), including induction of apoptosis (Lin et al., 1995Go). SIN1, although it is not a strong NO donor, is capable of releasing both NO and superoxide simultaneously, hence generating peroxinitrite (Hogg et al., 1992Go). In the present study, either addition of SIN1 or the NO catabolites to culture had no significant effects on aromatase activities, confirming that the action of NO donors are NO-related.

So far, the molecular mechanisms of inhibitory actions of NO on aromatase has been partially elucidated. Similar to the actions found for hepatic cytochrome P-450 enzymes (Stadler et al., 1994Go), the inhibitory actions of NO on aromatase are thought to involve two different mechanisms, one of which is the direct effect on the enzyme, and another of which is decreasing mRNA values for the enzymes (Snyder et al., 1996Go). A direct inhibitory effect of NO appears to be mediated by the formation of a nitrosothiol group of the cysteine residue in aromatase, rather than by the direct binding to the heme iron, because carbon monoxide (a gas known to bind the heme iron in aromatase), had no effect on aromatase activity (Snyder et al., 1996Go). The present study demonstrated that NO donors caused a significant reduction of aromatase mRNA expression, supporting the hypothesis that the inhibitory action of NO on aromatase is, in part, attributable to the down-regulation of gene transcription.

The precise intracellular mechanisms mediating down-regulation of the aromatase gene transcription are not known. Although NO activates guanylate cyclase in many cells including human granulosa cells, the inhibitory effect of NO on aromatase is not mediated through a cyclic GMP signalling pathway, because addition of cyclic GMP analogues did not inhibit steroidogenesis (Van Voorhis et al., 1994Go; Masuda et al., 1997Go). Several recent studies have led to speculation about the existence of cyclic GMP-independent signal transduction pathway for NO actions: e.g. reports that treatment of cell membrane with NO decreases cAMP production (Duhe et al., 1994Go), and that some of the biological activities of NO may be mediated by cAMP-dependent mechanisms (Wang et al., 1997Go). Expression of aromatase gene in the ovary is thought to utilize a proximal promoter that is regulated primarily by cAMP (Means et al., 1989Go; Simpson et al., 1991Go, 1993Go), and treatment with NO donors was found to reduce intracellular cAMP values, suggesting that inhibition of basal values of aromatase activity by NO is mediated by a cAMP-dependent signal transduction pathway. However, this hypothesis was not supported by experiments using an inhibitor of protein kinase A, although the use of H89 alone is insufficient to elucidate the relationship between NO and the cAMP pathway.

The down-regulation of aromatase gene transcription in granulosa–luteal cells may be mediated through activation of protein kinase C, because C-kinase activators, such as gonadotrophin-releasing hormone and phorbol 12-myristate 13-acetate, have been reported to decrease basal values of aromatase mRNA in cultured granulosa cells from rats (Fitzpatrick et al, 1997Go) and ewes (Mcguire et al., 1994Go). In this study, we observed that the pharmacological activation of protein kinase C with phorbol esters induced reduction of basal aromatase activity in human granulosa–luteal cells in a dose-dependent manner. Whether NO modulates the intracellular calcium concentrations of human granulosa–luteal cells is the subject of our ongoing investigation.

Several studies have demonstrated relative importance of NO in the ovulatory process (Shukovsky and Tsafriri, 1994Go; Bonello et al., 1996Go; Yamauchi et al., 1997Go). However, effects of NO on steroidogenesis during ovulatory phase remains controversial. Although most previous reports have suggested that NO may act as a down-regulator of steroidogenesis in the ovary, contradictory data has been presented (Bonello et al., 1996Go) showing that administration of a NO synthase inhibitor inhibited oestrogen generation from the in-vitro perfused rat ovary, and have suggested that NO may stimulate oestrogen synthesis. Bonello et al. (Bonello et al., 1996Go) commented that the reduction of oestradiol may be attributable to the reduced flow rate due to vasoconstrictor effects of NOS inhibitors, and these results cannot be compared with those of most previous studies using isolated in-vitro cells, which lacked an intact vascular system. However, inhibition of endogenous NO synthase in the in-vitro perfused rabbit ovaries resulted in a significant elevation in the production of oestradiol stimulated by HCG (Yamauchi et al., 1997Go). The discrepancy between the results of two studies may be due to species differences.

Effects of NO on progesterone synthesis have also been investigated. Administration of NO donor inhibited progesterone synthesis of cultured human granulosa cells (Van Voorhis et al., 1994Go), and we also confirmed these results (data not shown). However, because the effects of NO on progesterone synthesis were one-order weaker than that on oestradiol (Van Voorhis et al., 1994Go), a role of NO in the regulation of ovarian progesterone synthesis appears to be less significant.

In conclusion, there were no significant effects in the NO catabolites or peroxinitrite on aromatase activity of human granulosa–luteal cells, confirming that inhibitory action of NO donors on aromatase is related to NO release. The action of NO is, in part, attributable to the down-regulation of aromatase gene transcription. Although NO caused reduction in the intracellular cAMP values, the down-regulation of aromatase gene transcription appears to be independent of the protein kinase A inhibition.


    Notes
 
3 To whom correspondence should be addressed Back


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Ahsan, S., Lacey, M. and Whitehead, S.A. (1997) Interactions between interleukin-1 beta, nitric oxide and prostaglandin E2 in the rat ovary: effects on steroidogenesis. Eur. J. Endocrinol. 137, 293–300.[Abstract]

Bonello, N., McKie, K., Jasper, M. et al. (1996) Inhibition of nitric oxide:effect on interleukin-1-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biol. Reprod. 54, 436–445.[Abstract]

Ben-Shlomo, D., Kokia, E., Jackson, M.J. et al. (1994) Interleukin-1 stimulates nitrite production in rat ovary: evidence for heterologous cell-cell interaction and for insulin-mediated regulation of the inducible isoform of nitric oxide sythase. Biol. Reprod. 51, 310–318.[Abstract]

Chomczynski, P.H. and Sacchi, N. (1987) Single-step methods of RNA isolation by guanidinium thiocyanate–phenol–chloroform extraction. Anal. Biochem. 162, 156–160.[ISI][Medline]

Chun, S.Y., Eisenhauer, K.M., Kubo, M. and Hsueh, A.J. (1995) Interleukin-1 beta suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology. 136, 3120–7.[Abstract]

Duhe, R.J., Nielsen, M.D., Dittman, A.H. et al. (1994) Oxidation of critical cysteine residues of type I adenylyl cyclase by o-iodosobenzoate or nitric oxide reversibly inhibits stimulation by calcium and calmodulin. J. Biol. Chem. 269, 7290–6.[Abstract/Free Full Text]

Fitzpatrick, S.L., Carlone, D.L., Robker, R.L. and Richards, J.S. (1997) Expression of aromatase in the ovary: down-regulation of mRNA by the ovulatory luteinizing hormone surge. Steroids, 62, 197–206.[ISI][Medline]

Garzo, V.G. and Dorrington, J.H., (1984) Aromatase activity in human granulosa cells during follicular development and the modulation by follicle-stimulating hormone and insulin. Am. J. Obstet. Gynecol., 148, 657–662.[ISI][Medline]

Harada, N. (1988) Cloning of a complete cDNA encoding human aromatase: immunochemical identification and sequence analysis. Biochem. Biophys. Res. Commun., 156, 725–732.[ISI][Medline]

Hogg, N., Darley-Usmar, V.M., Wilson, M.T. and Moncada, S. (1992) Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem. J., 281, 419–424.

Ignarro, L.J., Adams, J.B., Horwitz, P.M. and Wood, K.S. (1986) Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms. J. Biol. Chem., 261, 4997–5002.[Abstract/Free Full Text]

Jablonka-Shariff, A. and Olson, L.M. (1997) Hormonal regulation of nitric oxide synthases and their cell-specific expression during follicular development in the rat ovary. Endocrinology, 138, 460–468.[Abstract/Free Full Text]

Lin, K.T., Xue, J.Y., Nomen, M. et al. (1995) Peroxinitrite-induced apoptosis in HL-60 cells. J. Biol. Chem., 270, 16487–16490.[Abstract/Free Full Text]

Lipton, S.A., Choi, Y.B., Pan, Z.H. et al. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature, 364, 626–632.[Medline]

Masuda, M., Kubota, T., Karnada, S. and Aso, T. (1997) Nitric oxide inhibits steroidogenesis in cultured porcine granulosa cells. Mol. Hum. Reprod., 3, 285–292.[Abstract/Free Full Text]

Matsumi, H., Yano, T., Koji, T. et al. (1998) Expression and localization of inducible nitric oxide synthase in the rat ovary: a possible involvement of nitric oxide in the follicular development. Biochem. Biophys. Res. Commun., 243, 67–72.[ISI][Medline]

Mcguire, W.J., Juengel, J.L. and Niswender, G.D. (1994) Protein kinase C second messenger system mediates the antisteroidogenic effects of prostaglandin F2{alpha} in the ovine corpus luteum in vitro. Biol. Reprod. 51, 800–806.[Abstract]

Means, G.D., Mahendroo, M.S., Corbin, C.J. et al. (1989) Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J. Biol. Chem., 264, 19385–19391.[Abstract/Free Full Text]

Moncada, S., Palmer, R.M.J. and Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacolm. Rev., 43, 109–142.

Motta, A.B., Franchi, A.M. and Gimeno, M.F. (1997) Role of nitric oxide on uterine and ovarian prostaglandin synthesis during luteolysis in the rat. Prostaglandins Leukot. Essent. Fatty Acids, 56, 265–269.[ISI][Medline]

Olson, L.M., Jones-Burton, C.M. and Jablonka-Shariff, A. (1996) Nitric oxide decreases estradiol synthesis of rat luteinized ovarian cells: possible role for nitric oxide in functional luteal regression. Endocrinology, 137, 3531–3539.[Abstract]

Salvemini, D., Misko, T.P., Masferrer, J.L. et al. (1993) Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA, 90, 7240–7244.[Abstract/Free Full Text]

Shukovsky, L. and Tsafriri, A. (1994) The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology, 135, 2287–2290.[Abstract]

Simpson, E.R., Lauber, M., Demeter, M. et al. (1991) Regulation of expression of the genes encoding steroidogenic enzymes. J. Steroid. Biochem. Mol. Biol., 40, 45–52.[ISI][Medline]

Simpson, E.R., Mahendroo, M.S., Means, G.D. et al. (1993) Tissue-specific promoters regulate aromatase cytochrome P450 expression. Clin. Chem., 39, 317–324.[Abstract]

Snyder, G.D., Holmes, R.W., Bates, J.N. and Van-Voorhis, B.J. (1996) Nitric oxide inhibits aromatase activity: mechanisms of action. J. Steroid. Biochem. Mol. Biol., 58, 63–69.[ISI][Medline]

Stadler, J., Trockfeld, J., Schmalix, W.A. et al. (1994) Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. USA, 91, 3559–3563.[Abstract/Free Full Text]

Van Voorhis, B.J., Dunn, M.S., Snyder, G.D. and Weiner, C.P. (1994) Nitric oxide: an autocrine regulator of human granulosa–luteal cell steroidogenesis. Endocrinology, 135, 1799–1806.[Abstract]

Van Voorhis, B.J., Moor, K., Strijbos, P.J.L.M. et al. (1995) Expression and localization of inducible and endothelial nitric oxide synthetase in the rat ovary. J. Clin. Invest., 96, 2719–2726.

Wang, S., Yan, L., Wesley, R.A. and Danner, R.L. (1997) Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP. J. Biol. Chem., 272, 5959–5965.[Abstract/Free Full Text]

Wink, D.A., Osawa, Y., Darbyshire, J.F. et al. (1993) Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys., 300, 115–123.[ISI][Medline]

Yamauchi, J., Miyazaki, T., Iwasaki, S. et al. (1997) Effects of nitric oxide on ovulation and ovarian steroidogenesis and prostaglandin production in the rabbit. Endocrinology, 138, 3630–3637.[Abstract/Free Full Text]

Zackrisson, U., Mikuni M., Wallin A. et al. (1996) Cell-specific localization of nitric oxide synthases (NOS) in the rat ovary during follicular development, ovulation and luteal formation. Hum. Reprod., 11, 2667–2673.[Abstract/Free Full Text]

Submitted on October 26, 1998; accepted on February 8, 1999.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Genes Dev.Home page
R. Duggavathi, D. H. Volle, C. Mataki, M. C. Antal, N. Messaddeq, J. Auwerx, B. D. Murphy, and K. Schoonjans
Liver receptor homolog 1 is essential for ovulation
Genes & Dev., July 15, 2008; 22(14): 1871 - 1876.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Taupeau, J. Poupon, D. Treton, A. Brosse, Y. Richard, and V. Machelon
Lead Reduces Messenger RNA and Protein Levels of Cytochrome P450 Aromatase and Estrogen Receptor {beta} in Human Ovarian Granulosa Cells
Biol Reprod, June 1, 2003; 68(6): 1982 - 1988.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
C. Tamanini, G. Basini, F. Grasselli, and M. Tirelli
Nitric oxide and the ovary
J Anim Sci, February 1, 2003; 81(14_suppl_2): E1 - 7.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
F. M. Reis, A. Faletti, S. Luisi, G. Bifulco, S. Cauci, F. Quadrifoglio, J. Dor, and F. Petraglia
High concentrations of inhibin A and inhibin B in ovarian serous cystadenoma: relationship with oestradiol and nitric oxide metabolites
Mol. Hum. Reprod., December 1, 2000; 6(12): 1079 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Vega, L. Urrutia, G. Iniguez, F. Gabler, L. Devoto, and M.C. Johnson
Nitric oxide induces apoptosis in the human corpus luteum in vitro
Mol. Hum. Reprod., August 1, 2000; 6(8): 681 - 687.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kagabu, S.
Right arrow Articles by Tanaka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kagabu, S.
Right arrow Articles by Tanaka, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?